Background: The Cosmetics Europe ADME Task Force is developing in vitro and in silico tools for predicting skin and systemic concentrations after topical application of cosmetic ingredients. There are conflicting reports as to whether the freezing process affects the penetration of chemicals; therefore, we evaluated whether the storage of human skin used in our studies (8-12 weeks at -20°C) affected the penetration of model chemicals. Methods: Finite doses of trans-cinnamic acid (TCA), benzoic acid (BA), and 6-methylcoumarin (6MC) (non-volatile, non-protein reactive and metabolically stable in skin) were applied to fresh and thawed frozen skin from the same donors. The amounts of chemicals in different skin compartments were analysed after 24 h. Results: Although there were some statistical differences in some parameters for 1 or 2 donors, the penetration of TCA, BA, and 6MC was essentially the same in fresh and frozen skin, i.e., there were no biologically relevant differences in penetration values. Statistical differences that were evident indicated that penetration was marginally lower in frozen than in fresh skin, indicating that the barrier function of the skin was not lost. Conclusion: The penetration of the 3 chemicals was essentially unaffected by freezing the skin at -20°C for up to 12 weeks.

1.
OECD, 2004a. Guidance document for the conduct of skin absorption studies. OECD series on testing and assessment (No 28), March 5, 2004.
2.
OECD, 2004b. OECD guideline for the testing of chemicals. Skin absorption: in vitro method. No 428. Adopted April 13, 2004.
3.
SCCS, 2010 (SCCS/1358/10). SCCS (Scientific Committee on Consumer Safety) basic criteria for the in vitro assessment of dermal absorption of cosmetic ingredients. June 22, 2010.
4.
Zalko D, Jacques C, Duplan H, Bruel S, Perdu E: Viable skin efficiently absorbs and metabolizes bisphenol A. Chemosphere 2011;82:424-430.
5.
Hewitt PG, Perkins J, Hotchkiss SA: Metabolism of fluroxypyr, fluroxypyr methyl ester, and the herbicide fluroxypyr methylheptyl ester. I. During percutaneous absorption through fresh rat and human skin in vitro. Drug Metab Dispos 2000;28:748-754.
6.
Jacques C, Perdu E, Duplan H, Jamin EL, Canlet C, Debrauwer L, Cravedi JP, Mavon A, Zalko D: Disposition and biotransformation of 14C-benzo(a)pyrene in a pig ear skin model: ex vivo and in vitro approaches. Toxicol Lett 2010;199:22-33.
7.
Jacques C, Perdu E, Jamin EL, Cravedi JP, Mavon A, Duplan H, Zalko D: Effect of skin metabolism on dermal delivery of testosterone: qualitative assessment using a new short-term skin model. Skin Pharmacol Physiol 2014;27:188.
8.
Chilcott RP, Dalton CH, Emmanuel AJ, Allen CE, Bradley ST: Transepidermal water loss does not correlate with skin barrier function in vitro. J Invest Dermatol 2002;118:871-875.
9.
Swarbrick J, Lee G, Brom J: Drug permeation through human skin. I. Effect of storage conditions of skin. J Invest Dermatol 1982;78:63-66.
10.
Moody RP, Martineau PA: An automated in vitro dermal absorption procedure. I. Permeation of (14)C-labelled N,N-diethyl-m-toluamide through human skin and effects of short-wave ultraviolet radiation on permeation. Toxicol In Vitro 1990;4:193-199.
11.
Nácher A, Bossó V, Meliá M, Garrigues TM, Martin A, Díez O, Herráez M: Preliminary study with phenol red to evaluate the integrity of human epidermis in in vitro permeation experiments. http://www.sefig.org/doc/SALAMANCA2005-pdf/BIOFARMACIA/BIOF-005.%20Nacher%20y%20col.pdf.
12.
Brain KR, Walters KA, Green DM, Brain S, Loretz LJ, Sharma RK, Dressler WE: Percutaneous penetration of diethanolamine through human skin in vitro: application from cosmetic vehicles. Food Chem Toxicol 2005;43:681-690.
13.
Moody RP, Yip A, Chu I: Effect of cold storage on in vitro human skin absorption of six 14C-radiolabeled environmental contaminants: benzo[a]pyrene, ethylene glycol, methyl parathion, naphthalene, nonyl phenol, and toluene. J Toxicol Environ Health A 2009;72:505-517.
14.
Hawkins GS Jr, Reifenrath WG: Development of an in vitro model for determining the fate of chemicals applied to skin. Fundam Appl Toxicol 1984;4:S133-S144.
15.
Kemppainen BW, Riley RT, Pace JG, Hoerr FJ: Effects of skin storage conditions and concentration of applied dose on [3H]T-2 toxin penetration through excised human and monkey skin. Food Chem Toxicol 1986;24:221-227.
16.
Gerstel D, Jacques-Jamin C, Schepky A, Cubberley R, Eilstein J, Grégoire S, Hewitt N, Klaric M, Rothe H, Duplan H: Comparison of protocols for measuring cosmetic ingredient distribution in human and pig skin. Toxicol In Vitro 2016;34:153-160.
17.
Fluhr JW, Feingold KR, Elias PM: Transepidermal water loss reflects permeability barrier status: validation in human and rodent in vivo and ex vivo models. Exp Dermatol 2006;15:483-492.
18.
Dennerlein K, Schneider D, Göen T, Schaller KH, Drexler H, Korinth G: Studies on percutaneous penetration of chemicals - impact of storage conditions for excised human skin. Toxicol In Vitro 2013;27:708-713.
19.
Harrison SM, Barry BW, Dugard PH: Effects of freezing on human skin permeability. J Pharm Pharmacol 1984;36:261-262.
20.
Bronaugh RL, Stewart RF, Simon M: Methods for in vitro percutaneous absorption studies. VII. Use of excised human skin. J Pharm Sci 1986;75:1094-1097.
21.
ACD/Labs, 2014. Percepta predictors - aqueous solubility, version 12. Toronto, Advanced Chemistry Development Inc., 2014. www.acdlabs.com.
22.
Willighagen EL, Denissen HM, Wehrens R, Buydens LM: On the use of 1H and 13C 1D NMR spectra as QSPR descriptors. J Chem Inf Model 2006;46:487-494.
23.
Hansch C, Leo AJ: Database. Pomona College Medicinal Chemistry Project. Claremont, Pomona College, 1995.
24.
US EPA: Estimation Programs Interface Suite™ for Microsoft® Windows, v 4.11. Washington, United States Environmental Protection Agency, 2015.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.